About
Novel Microdevices develops portable, battery-powered rapid PCR diagnostic platforms that provide lab-quality molecular testing results for infectious diseases such as Flu, RSV, COVID-19, and STIs in approximately 15 minutes at the point of care.
Explore Novel Microdevices's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.